Post by
tamaracktop on Mar 31, 2022 8:59am
Aaron MacNeil
I don't know how anyone could make seripous investment decisions based on TD's research on Xebec anymore.
Particularly after his botched call exactly 15 months ago, less than 2 weeks before the high.
He's still smarting from that.
More like dumbing.
Xebec had closed at $7.99 the day before Aaron's report came out.
Remember his investment conclusions on December 31, 2020:
"Although a presumption of future growth is reflected in Xebec’s forward-year valuation multiples, we believe that our NAV calculation better reflects the intrinsic value and implies a much higher valuation. As a result, we are resuming coverage on Xebec Adsorption Inc. (XBC-V) with a BUY rating and $12.50 target price."
It's TD that should be in the penalty box, not Xebec.
When Xebec shares rally substantially from here, if anyone had bought and then sold a sizable position based on TD's research, I imagine TD might be vulnerable to litigation.
Comment by
filoux004 on Mar 31, 2022 9:20am
Don't want to contradict you, but since BreX scandal, the courts have ruled that brokerage firms do not have a fiduciary duty in guaranteeing the returns of their opinions. In other words litigating against a brokerage for their opinions is akeen to climbing mount Everest. Long XBC Oeace